Invesaro

Stocks ZGN Financial statements

Financial statements

Ermenegildo Zegna N.V. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Ermenegildo Zegna N.V. files with the SEC in its annual reports.

In EUR millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Revenue1,3211,0151,2921,4931,9051,9471,917
Cost of revenue496565680650623
Gross profit7979281,2241,2971,294
Selling, general and administrative8236959011,0081,034
Operating income88.6-22.6-94148208167139
Interest expense37.548.143.854.368.15250.5
Interest income22.134.445.913.337.32641.5
Pre-tax income69.2-31.6-97101169131140
Income tax43.81530.735.833.439.730.6
Net income to minority interests3.694.048.3413.814.113.810.9
Net income21.7-50.6-13651.512277.198.6
EBITDA25714460.6320401392384
EPS, basic0.11-0.25-0.670.220.490.310.38
EPS, diluted0.11-0.25-0.670.210.480.300.38

Balance sheet

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents211317460254296219220
Receivables139160177240249227
Inventory321338411523521507
Total current assets1,2391,3851,2861,2881,2061,190
Property, plant and equipment244111126160205211
Lease right-of-use assets459352370376534581652
Goodwill420388425456572614554
Total assets2,4152,4582,4272,7672,8342,835
Accounts payable188223271314310326
Total current liabilities5357028671,012853750
Lease liabilities315331332471519591
Total liabilities1,7701,8131,6941,8661,8511,736
Total debt665629471403374246
Retained earnings893499528
Shareholders' equity6026016798409161,031
Minority interests43.343.153.460.666.868.1
Total equity7306456447329019831,099
Total liabilities and equity2,4152,4582,4272,7672,8342,835

Cash flow statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Net income25.4-46.5-12865.313690.9109
Depreciation and amortization168166155172193225245
Cash from operations17470.9281146275279336
Capital expenditures-46.1-27.6-79.7-49.1-57-100-80.5
Cash from investing8492.6-82-57.321.8-126-110
Debt issued131265124020426049.9
Debt repaid-273-221-160-160-306-291-179
Stock issued0031100
Share buybacks00-45500
Dividends paid-14.9-1.73-0.65-26-25-30.3-30.5
Cash from financing-267-49.1-64.1-297-250-235-215
Exchange rate effect1.7-7.767.452.46-4.724.27-9.6
Net change in cash-7.71107143-20542-77.10.99
Free cash flow12843.320197.3218179255
Interest paid26.92117.524.929.238.139.6
Income taxes paid30.936.463.349.35452.837.5

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Gross margin67.5%Gross profit / revenue.
Operating margin7.3%Operating income / revenue.
EBITDA margin20.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin7.3%Pre-tax income / revenue.
Net margin5.1%Net income / revenue.
FCF margin13.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin17.5%Cash from operations / revenue.
Effective tax rate21.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)10.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)3.5%Net income / average total assets.
Return on invested capital (ROIC)10.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue53.9%Selling, general and administrative expense / revenue.
Capex / revenue4.2%Capital expenditures / revenue.
D&A / revenue12.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-0.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y-16.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-1.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y-1.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y6.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y21.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y27.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y26.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y21.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y20.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y31.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y36.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y42.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y37.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y42.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y12.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y14.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y11.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y0.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.59xCurrent assets / current liabilities.
Quick ratio0.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.29x(Cash + short-term investments) / current liabilities.
Debt / equity0.24xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets8.7%Total debt / total assets.
Liabilities / assets61.2%Total liabilities / total assets.
Net debt€26.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.07xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.76xOperating income / interest expense.
Working capital€439.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets19.5%(Goodwill + intangible assets) / total assets.
Tangible book value€476.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.68xRevenue / average total assets.
Fixed asset turnover9.21xRevenue / average property, plant and equipment.
Inventory turnover1.21xCost of revenue / average inventory.
Days inventory301 days365 x average inventory / cost of revenue.
Receivables turnover8.06xRevenue / average receivables.
Days sales outstanding45 days365 x average receivables / revenue.
Days payables186 days365 x average accounts payable / cost of revenue.
Cash conversion cycle160 daysDays inventory + days sales outstanding - days payables.
FCF conversion258.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow24.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted€0.38Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic€0.38Net income per basic share, as reported (split-adjusted).
Payout ratio30.9%Dividends paid / net income, when net income is positive.
Dividends / FCF12.0%Dividends paid / free cash flow, when free cash flow is positive.
What was Ermenegildo Zegna N.V.'s revenue in fiscal 2025?

Ermenegildo Zegna N.V. reported revenue of €1.92B for fiscal 2025, 1.5% lower than the year before.

Was Ermenegildo Zegna N.V. profitable in fiscal 2025?

Yes. Net income was €98.6M, a net margin of 5.1%.

How much free cash flow did Ermenegildo Zegna N.V. generate in fiscal 2025?

Cash from operations of €335.6M minus capital expenditures of €80.5M left free cash flow of €255.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Ermenegildo Zegna N.V.